Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral and Topical Use of Phytocannabinoids for Patients With Psoriasis Vulgaris: An Open-Label Prospective Study - CBDermis

NCT07839455 is registered in ClinicalTrials.gov with Federal University of Latin American Integration as lead sponsor.

NCT NCT07839455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07839455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral and Topical Use of Phytocannabinoids for Patients With Psoriasis Vulgaris: An Open-Label Prospective Study - CBDermis
Lead sponsor
Federal University of Latin American Integration
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 1, 2025
Completion date
February 28, 2027
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris